These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 6563944)
41. In vitro modulation of mouse natural killer (NK) cell activity by the serum thymic factor (FTS). Kaiserlian D; Bardos P; Bach JF Cell Immunol; 1983 Mar; 76(2):232-42. PubMed ID: 6682352 [TBL] [Abstract][Full Text] [Related]
42. Thymosin alpha 1 effects, in vitro, on lymphokine-activated killer cells from patients with primary immunodeficiencies: preliminary results. Eckert K; Schmitt M; Garbin F; Wahn U; Maurer HR Int J Immunopharmacol; 1994 Dec; 16(12):1019-25. PubMed ID: 7705963 [TBL] [Abstract][Full Text] [Related]
43. Natural killer cell activity associated with reticulum cell neoplasms. Chang KS; Log T Int J Cancer; 1980 Mar; 25(3):405-16. PubMed ID: 6248470 [TBL] [Abstract][Full Text] [Related]
44. Induction of lymphokine-activated killer activity in mice by prothymosin alpha. Baxevanis CN; Gritzapis AD; Dedoussis GV; Papadopoulos NG; Tsolas O; Papamichail M Cancer Immunol Immunother; 1994 Apr; 38(4):281-6. PubMed ID: 8168124 [TBL] [Abstract][Full Text] [Related]
45. Studies of the thymus in mice bearing the Lewis lung carcinoma. II. Modulation of thymic natural killer activity by thymulin (FTS-Zn) and the antimetastatic effect of zinc. Kaiserlian D; Savino W; Dardenne M Clin Immunol Immunopathol; 1983 Aug; 28(2):192-204. PubMed ID: 6688208 [TBL] [Abstract][Full Text] [Related]
46. [Comparative study of the effect of thymosin and supernatant from epithelial thymic cells on antibody production (author's transl)]. Deschaux P; Fontanges R; Goldstein A Experientia; 1979 May; 35(5):678-81. PubMed ID: 376337 [TBL] [Abstract][Full Text] [Related]
47. Studies of the thymus in mice bearing the Lewis lung carcinoma. I. Thymic natural killer cell activity in 3LL tumor-bearing mice. Kaiserlian D; Savino W; Bach JF Cell Immunol; 1983 Aug; 80(1):187-97. PubMed ID: 6872007 [TBL] [Abstract][Full Text] [Related]
48. In vitro enhancement of bone marrow natural killer cells after incubation with thymopoietin32-36 (TP-5). Fiorilli M; Sirianni MC; Sorrentino V; Testi R; Aiuti F Thymus; 1983 Sep; 5(5-6):375-82. PubMed ID: 6197787 [TBL] [Abstract][Full Text] [Related]
49. Involvement of mitogen-activated protein kinases in the signal transduction pathway of bone marrow-derived macrophage activation in response to in vitro treatment with thymosin alpha 1. Sodhi A; Paul S Int Immunopharmacol; 2002 Jan; 2(1):47-58. PubMed ID: 11789669 [TBL] [Abstract][Full Text] [Related]
50. Macrophage-mediated suppression of natural killer cell activity in mice bearing Lewis lung carcinoma. Young MR; Wheeler E; Newby M J Natl Cancer Inst; 1986 Apr; 76(4):745-50. PubMed ID: 3457207 [TBL] [Abstract][Full Text] [Related]
51. A functional comparison of tumor cell killing by activated macrophages and natural killer cells. Roder JC; Lohmann-Matthes ML; Domzig W; Kiessling R; Haller O Eur J Immunol; 1979 Apr; 9(4):283-8. PubMed ID: 467492 [TBL] [Abstract][Full Text] [Related]
52. Natural cytotoxicity of mouse, rat, and human lymphocytes against heterologous target cells. Nunn ME; Herberman RB J Natl Cancer Inst; 1979 Apr; 62(4):765-71. PubMed ID: 285291 [TBL] [Abstract][Full Text] [Related]
53. Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver. Wiltrout RH; Mathieson BJ; Talmadge JE; Reynolds CW; Zhang SR; Herberman RB; Ortaldo JR J Exp Med; 1984 Nov; 160(5):1431-49. PubMed ID: 6491601 [TBL] [Abstract][Full Text] [Related]
57. Natural cytotoxic cells against solid tumors in mice. III. A comparison of effector cell antigenic phenotype and target cell recognition structures with those of NK cells. Lattime EC; Pecoraro GA; Stutman O J Immunol; 1981 May; 126(5):2011-4. PubMed ID: 7217680 [TBL] [Abstract][Full Text] [Related]
58. Variation in selectivity of tumor cell cytolysis by murine macrophages, macrophage-like cell lines and NK cells. Wiltrout RH; Brunda MJ; Holden HT Int J Cancer; 1982 Sep; 30(3):335-42. PubMed ID: 6813271 [TBL] [Abstract][Full Text] [Related]
59. Natural killer cells may be the only cells in normal mouse lymphoid cell populations endowed with cytolytic ability for antibody-coated tumour target cells. Ojo E; Wigzell H Scand J Immunol; 1978 Apr; 7(4):297-306. PubMed ID: 418499 [TBL] [Abstract][Full Text] [Related]
60. Correlation between natural and antibody-dependent cell-mediated cytotoxicity against tumor targets in the mouse. II. Characterization of the effector cells. Santoni A; Herberman RB; Holden HT J Natl Cancer Inst; 1979 Oct; 63(4):995-1003. PubMed ID: 384012 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]